LNTH Q1 2017 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$81M+6.4% YoY

Gross Profit

$40M48.9% margin

Operating Income

$12M14.7% margin

Net Income

$4M5.1% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+9.4%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$625,000

Stock-Based Comp.

$945,000

Balance Sheet

Total Assets

$250M

Total Liabilities

$351M

Stockholders' Equity

-$101M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$81M	$76M	+6.4%
Gross Profit	$40M	$34M	+18.0%
Operating Income	$12M	$18M	-32.5%
Net Income	$4M	$10M	-59.9%

Revenue Segments

US Segment

$71M87%

International Segment

$10M13%